• 1
    Holan KR, Holzbach RT, Hermann RE, Cooperman AM, Claffey WJ. Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease. Gastroenterology 1979; 77: 611617.
  • 2
    Groen AK, Stout JPJ, Drapers JAG, Hoek FJ, Grijm R, Tytgat GNJ. Cholesterol nucleation influencing activity in T-tube bile. Hepatology 1988; 8: 347352.
  • 3
    Holzbach RT, Kibe A, Thiel E, Howell JH, Marsh M, Hermann RE. Biliary proteins: unique inhibitors of cholesterol crystal nucleation in human gallbladder bile. J Clin Invest 1984; 73: 3545.
  • 4
    Van Erpecum KJ, vanBerge-Henegouwen GP, Stoelwinder B, Schmidt YMG, Willekens FLH. Bile concentration is a key factor for nucleation of cholesterol crystals and cholesterol saturation index in gallbladder bile of gallstone patients. Hepatology 1990; 11: 16.
  • 5
    Jungst D, Lang T, von Ritter C, Pratschke E, Paumgartner G. Cholesterol nucleation time in gallbladder bile of patients with solitary or multiple cholesterol gallstones. Hepatology 1992; 15: 804808.
  • 6
    Villanova N, Bazzoli F, Taroni F, Frabboni R, Mazzella G, Festi D, Barbara L. et al. Gallstone recurrence after successful oral bile acid treatment: a 12 year follow-up study and evaluation of long term postdissolution treatment. Gastroenterology 1989; 97: 726731.
  • 7
    Groen AK, Noordam C, Drapers JAG, Egbers P, Jansen PLM, Tytgat GNJ. Isolation of a potent cholesterol nucleation-promoting activity from human gallbladder bile of patients with solitary or multiple cholesterol gallstones. Hepatology 1990; 11: 525533.
  • 8
    Van Erpecum KJ, Stolk MFJ, van den Broek AMWC, Renooij W, van de Heijning BJM, vanBerge-Henegouwen GP. Bile concentration promotes nucleation of cholesterol monohydrate crystals by increasing the cholesterol concentration in the vesicles. Eur J Clin Invest 1993; 23: 283288.
  • 9
    Strasberg SM, Toth JL, Gallinger S, Harvey PR. High protein and total lipid concentration are associated with reduced meta-stability of bile in an early stage of cholesterol gallstone formation. Gastroenterology 1990; 98: 739746.
  • 10
    Van Erpecum KJ, vanBerge-Henegouwen GP, Stoelwinder B, Stolk MFJ, Eggink WF, Govaert WHA. Cholesterol and pigment gallstone disease: comparison of the reliability of three bile tests for differentiation between the two stone types. Scand J Gastroenterol 1988; 23: 948954.
  • 11
    Van Erpecum KJ, vanBerge-Henegouwen GP, Stolk MFJ, Hopman WPM, Jansen JBMJ, Lamers CBHW. Fasting gallbladder volume, postprandial emptying and cholecystokinin release in gallstone patients and normal subjects. J Hepatol 1992; 14: 194202.
  • 12
    Portincasa P, Di Ciaula A, Baldassarre G, Palmieri V, Gentile A, Cimmino A, Palasciano G. Gallbladder motor function in gallstone patients: sonographic and in vitro studies on the role of gallstones, smooth muscle function and gallbladder wall inflammation. J Hepatol 1994; 21: 430440.
  • 13
    Stolk MFJ, Van Erpecum KJ, Renooij W, Portincasa P, van de Heijning BJM, vanBerge-Henegouwen GP. Gallbladder emptying in vivo, bile composition and nucleation of cholesterol crystals in patients with cholesterol gallstones. Gastroenterology 1995; 108: 18821888.
  • 14
    Marcus SN, Heaton KW. Intestinal transit, deoxycholic acid and the cholesterol saturation of bile: three inter-related factors. Gut 1986; 27: 550558.
  • 15
    Marcus SN, Heaton KW. Deoxycholic acid and the pathogenesis of gall stones. Gut 1988; 29: 522533.
  • 16
    Konikoff FM, Chung DS, Donovan JM, Small DM, Carey MC. Filamentous, helical and tubular microstructures during cholesterol crystallization from bile. Evidence that biliary cholesterol does not nucleate classic monohydrate plates. J Clin Invest 1992; 90: 11561161.
  • 17
    Konikoff FM, Cohen DE, Carey MC. Phospholipid molecular species influence crystal habits and transition sequences of metastable intermediates during cholesterol crystallization from bile salt-rich model bile. J Lipid Res 1994; 35: 6070.
  • 18
    Wang DOH, Carey MC. The complete mapping of cholesterol crystal nucleation paths in model and native bile. [Abstract] Gastroenterology 1994; 106: 1004A.
  • 19
    Tera H. Stratification of human gallbladder bile in vivo. Acta Chir Scand 1960; 256(suppl): 485.
  • 20
    Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37: 911917.
  • 21
    Fromm H, Hamin P, Klein H, Kupke I. Use of a simple enzymatic assay for cholesterol analysis in human bile. J Lipid Res 1980; 21: 259261.
  • 22
    Trotman BW, Ostrow JD, Soloway RD. Pigment vs. cholesterol cholelithiasis: comparison of stone type and bile composition. Am J Dig Dis 1974; 19: 585590.
  • 23
    Turley SD, Dietschy JM. Reevaluation of the 3-hydroxy-steroid dehydrogenase assay for total bile acids in bile. J Lipid Res 1978; 19: 924928.
  • 24
    Carey MC. Critical tables for calculating the cholesterol saturation of native bile. J Lipid Res 1978; 19: 945955.
  • 25
    Tint GS, Salen G, Shefer S. Effect of ursodeoxycholic acid and chenodeoxycholic acid on cholesterol and bile acid metabolism. Gastroenterology 1986; 91: 10071018.
  • 26
    Ruben AT, vanBerge-Henegouwen GP. A simple reverse-phase high pressure liquid chromatographic determination of conjugated bile acids in serum and bile using a novel radial compression separation system. Clin Chim Acta 1982; 11: 941950.
  • 27
    Heuman DM. Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions. J Lipid Res 1989; 30: 719730.
  • 28
    Pattinson NR, Willis KE. Nucleation of cholesterol crystals from native bile and the effect of protein hydrolysis. J Lipid Res 1991; 32: 215221.
  • 29
    Stolk MFJ, van de Heijning BJM, Van Erpecum KJ, van de Broek AMWC, Renooij W, vanBerge-Henegouwen GP. The effect of bile salt hydrophobicity on nucleation of several types of cholesterol crystals from model bile vesicles. J Hepatology 1994; 20: 802810.
  • 30
    Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457481.
  • 31
    Armitage P, Berry G. Statistical methods in medical research. 2nd Ed. Cambridge, MA: Blackwell Scientific, 1987: 296.
  • 32
    Salvioli G, Igimi H, Carey MC. Cholesterol gallstone dissolution in bile. Dissolution kinetics of crystalline cholesterol monohy-drate by conjugated chenodeoxycholate-lecithin and conjugated ursodeoxycholate-lecithin mixtures: dissimilar phase equilibria and dissolution mechanisms. J Lipid Res 1983; 24: 701720.
  • 33
    Konikoff FM, Carey MC. Cholesterol crystallization from a dilute bile salt-rich model bile. J Crystal Growth 1994; 144: 7986.
  • 34
    Whiting MJ, Watts JM. Cholesterol crystal formation and growth in model bile solutions. J Lipid Res 1983; 24: 861868.
  • 35
    Van Erpecum KJ, Portincasa P, Stolk MFJ, van de Heijning BJM, van der Zaag ES, van den Broek AMWC, van Berge-Henegouwen GP. et al. Effects of bile salt and phospholipid hydrophobicity on lithogenicity of human gallbladder bile. Eur J Clin Invest 1994; 24: 744750.
  • 36
    Angelico M, Ginanni Corradini S, Masella R, Alvaro D, Cantafora A, Capocaccia L. Molecular composition of phosphatidylcho-lines, as related to cholesterol saturation, transport and nucleation in human-gallbladder bile. J Hepatol 1992; 15: 5966.
  • 37
    Kiyosawa R, Chijiiwa K, Hirota I, Nakayama F. Possible factors affecting the cholesterol nucleation time in human bile: a filtration study. J Gastroenterol Hepatol 1994; 7: 142147.
  • 38
    Schneider HT, Benninger J, Rabes U, Madani N, May A, Hahn EG, Ell C. Recurrent gallstone formation after successful extracorporeal shock-wave lithotripsy. Am J Gastroenterol 1993; 88: 13991404.
  • 39
    Heuman R, Norrby S, Sjodahl R, Tiselius HG, Tagesson C. Altered gallbladder bile composition in gallstone disease. Relation to gallbladder wall permeability. Scand J Gastroenterol 1980; 15: 581586.
  • 40
    Berr F, Pratschke E, Fischer S, Paumgartner G. Disorders of bile acid metabolism in cholesterol gallstone disease. J Clin Invest 1992; 90: 859868.
  • 41
    Donovan JM, Timofeyeva N, Carey MC. Cholesterol monohydrate (CHM) and liquid crystal formation in model biles: effects of bile salt (BS) hydrophobicity and phosphatidylcholine (PC) contents. [Abstract] Hepatology 1989; 10: 598.
  • 42
    Sahlin S, Ahlberg J, Angelin B, Ewerth S, Nilsell K, Reihner E, Einarsson K. Occurrence of cholesterol monohydrate crystals in gallbladder and hepatic bile in man: influence of bile acid treatment. Eur J Clin Invest 1988; 18: 386390.
  • 43
    Noshiro H, Chijiwa K, Makino I, Hirota I. Deoxycholic acid in gall bladder does not account for the shortened nucleation time in patients with cholesterol gall stones. Gut 1995; 36: 121125.
  • 44
    Makino I, Chijiiwa K, Higashijima H, Nakahara S, Kishinaka M, Kuroki A, Mibu R. Rapid cholesterol nucleation and cholesterol gall stone formation after subtotal or total colectomy in humans. Gut 1994; 35: 17601764.
  • 45
    Berr F, Mayer M, Sackmann M, Sauerbruch T, Holl J, Paumgartner G. Pathogenic factors in early recurrence of cholesterol gallstones. Gastroenterology 1994; 106: 215224.